Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Food Funct ; 6(3): 981-6, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25671677

RESUMO

Gastrointestinal mucositis induced by chemotherapy is associated with alterations of intestinal barrier function due to the potential damage induced by anti-cancer drugs on the epithelial cells. Goblet cells, an important epithelial lining in the intestine, contribute to innate immunity by secreting mucin glycoproteins. Employing a mouse model of chemotherapy induced intestinal mucosal immunity injury by cyclophosphamide, we demonstrated for the first time that polysaccharide from the ink of Ommastrephes bartramii (OBP) enhanced Cyto18, which is a mucin expression in goblet cells. The up-regulation of mucins by OBP relied on the augmented quantity of goblet cells, but not on the changes in the ultrastructure of endoplasmic reticulum (ER). Our results may have important implications for enhanced immunopotentiation function of functional OBP on intestinal mucosal immunity against intestinal disorders involving inflammation and infection.


Assuntos
Secreções Corporais/química , Decapodiformes/fisiologia , Suplementos Nutricionais , Células Caliciformes/metabolismo , Mucosite/prevenção & controle , Polissacarídeos/uso terapêutico , Substâncias Protetoras/uso terapêutico , Adjuvantes Imunológicos/isolamento & purificação , Adjuvantes Imunológicos/uso terapêutico , Animais , Antineoplásicos/efeitos adversos , Ciclofosfamida/efeitos adversos , Regulação da Expressão Gênica/efeitos dos fármacos , Células Caliciformes/efeitos dos fármacos , Células Caliciformes/ultraestrutura , Imunidade Inata/efeitos dos fármacos , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/metabolismo , Intestino Delgado/ultraestrutura , Queratina-18/agonistas , Queratina-18/genética , Queratina-18/metabolismo , Masculino , Camundongos Endogâmicos BALB C , Microscopia Eletrônica de Transmissão , Mucina-2/agonistas , Mucina-2/genética , Mucina-2/metabolismo , Mucosite/induzido quimicamente , Mucosite/metabolismo , Mucosite/patologia , Polissacarídeos/isolamento & purificação , Substâncias Protetoras/isolamento & purificação , Regulação para Cima/efeitos dos fármacos
2.
Biol Trace Elem Res ; 156(1-3): 153-65, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24178785

RESUMO

Fluoride (F) is a well-recognized hazardous substance. Ingested F initially acts locally on the intestines. The small intestine plays a critical role in the digestion, absorption, and defense. In this study, therefore, we investigated the effects of fluorine on the intestinal development by light microscopy, transmission electron microscopy, and histochemistry. A total of 280 one-day-old avian broilers were randomly divided into four groups and fed on a corn-soybean basal diet as control diet (fluorine, 22.6 mg/kg) or the same basal diet supplemented with 400, 800, and 1,200 mg/kg fluorine (high fluorine groups I, II, and III) in the form of sodium fluoride for 42 days. The results showed that the intestinal gross, histological, and ultrastructural changes were observed in the high fluorine groups II and III. Meanwhile, the intestinal length, weight, viscera index, villus height, crypt depth, villus height to crypt depth ratio, diameter, muscle layer thickness, and goblet cell numbers were significantly lower (p < 0.01 or p < 0.05), and the intestinal diameter to villus height ratio was markedly higher (p < 0.01 or p < 0.05) in the high fluorine groups II and III than those in control group. In conclusion, dietary fluorine in the range of 800-1,200 mg/kg obviously altered the aforementioned parameters of the intestines, implying that the intestinal development was suppressed and the intestinal functions, such as digestion, absorption, defense, or osmoregulation were impaired in broilers.


Assuntos
Cariostáticos/farmacologia , Suplementos Nutricionais , Flúor/farmacologia , Intestino Delgado/metabolismo , Fluoreto de Sódio/farmacologia , Animais , Galinhas , Feminino , Células Caliciformes/metabolismo , Células Caliciformes/ultraestrutura , Absorção Intestinal/efeitos dos fármacos , Intestino Delgado/ultraestrutura , Masculino , Osmorregulação/efeitos dos fármacos
3.
Iran J Allergy Asthma Immunol ; 11(4): 316-23, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23264408

RESUMO

Hedera helix is widely used to treat bronchial asthma for many years. However, effects of this herb on lung histopathology is still far from clear. We aimed to determine the effect of oral administration of Hedera helix on lung histopathology in a murine model of chronic asthma.BALB/c mice were divided into four groups; I (Placebo), II (Hedera helix), III (Dexamethasone) and IV (Control). All mice except controls were sensitized and challenged with ovalbumin. Then, mice in group I received saline, group II 100 mg/kg Hedera helix and group III 1 mg/kg dexamethasone via orogastic gavage once daily for one week. Airway histopathology was evaluated by using light and electron microscopy in all groups.Goblet cell numbers and thicknesses of basement membrane were found significantly lower in group II, but there was no statistically significant difference in terms of number of mast cells, thicknesses of epithelium and subepithelial smooth muscle layers between group I and II. When Hedera helix and dexamethasone groups were compared with each other, thickness of epithelium, subepithelial muscle layers, number of mast cells and goblet cells of group III were significantly ameliorated when compared with the group II. Although Hedera helix administration reduced only goblet cell counts and the thicknesses of basement membrane in the asthmatic airways, dexamethasone ameliorated all histopathologic parameters except thickness of basement membrane better than Hedera helix.


Assuntos
Remodelação das Vias Aéreas/efeitos dos fármacos , Antiasmáticos/farmacologia , Asma/tratamento farmacológico , Hedera , Pulmão/efeitos dos fármacos , Preparações de Plantas/farmacologia , Administração Oral , Animais , Antiasmáticos/administração & dosagem , Asma/imunologia , Asma/patologia , Membrana Basal/efeitos dos fármacos , Membrana Basal/ultraestrutura , Doença Crônica , Dexametasona/farmacologia , Modelos Animais de Doenças , Feminino , Células Caliciformes/efeitos dos fármacos , Células Caliciformes/ultraestrutura , Pulmão/imunologia , Pulmão/ultraestrutura , Camundongos , Camundongos Endogâmicos BALB C , Microscopia Eletrônica , Ovalbumina , Preparações de Plantas/administração & dosagem , Plantas Medicinais , Fatores de Tempo
4.
Artigo em Inglês | MEDLINE | ID: mdl-12000223

RESUMO

Modified hemoglobins are being considered as possible "blood substitutes." Experiments were performed to determine whether diaspirin cross-linked hemoglobin (DBBF-Hb) produces epithelial damage and whether this is reduced by selenium (Se). Anesthetized Sprague-Dawley rats, half of which received 2 x 10(-6) g/ml Se, daily for 3 weeks, in their drinking water, were injected with a 5 ml bolus of 10 mg/ml DBBF-Hb. Control animals received saline (5 animals per group). After 30 minutes, the intestine was perfusion-fixed for light and electron microscopy. Eighty villi per rat were assigned an epithelial integrity index (E.I.), ranging from 1 (intact) to 3 (some cell-cell and cell-basement membrane separation). In non-Se rats, E.I. was significantly compromised by DBBF-Hb, compared to HBS-BSA (2.47+/-0.57 (SD) vs. 1.36+/-0.49, p<0.001). In Se rats, neither injection with DBBF-Hb or HBS-BSA caused epithelial damage (1.03+/-0.17 vs. 1.07+/-0.26). Mast cell degranulation per villus (MCD) was measured in 60 villi per rat. In non-Se rats, MCD was significantly greater after DBBF-Hb than after HBS-BSA injection (1.83+/-1.42 vs. 0.2+/-0.4). Supplementary Se did not reduce this effect. In fact, MCD was significantly increased in both sets of rats compared to their non-Se counterparts (3.27+/-2.40 and 1.48+/-1.70 for DBBF-Hb and HBS-BSA, respectively). Since mast cell mediators damage cells, Se must protect the mucosal epithelium in some way.


Assuntos
Antioxidantes/farmacologia , Hemoglobinas/toxicidade , Mucosa Intestinal/efeitos dos fármacos , Selênio/farmacologia , Animais , Degranulação Celular/efeitos dos fármacos , Interações Medicamentosas , Células Caliciformes/efeitos dos fármacos , Células Caliciformes/metabolismo , Células Caliciformes/ultraestrutura , Mucosa Intestinal/citologia , Mucosa Intestinal/metabolismo , Masculino , Mastócitos/metabolismo , Mastócitos/ultraestrutura , Microscopia Eletrônica , Ratos , Ratos Sprague-Dawley , Espécies Reativas de Oxigênio/metabolismo
5.
Antimicrob Agents Chemother ; 44(8): 2039-45, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10898673

RESUMO

Antimicrobial peptides are proposed to act as the first line of mucosal host defense by exerting broad-spectrum microbicidal activity against pathogenic microbes. Pleurocidin, a new 25-residue linear antimicrobial peptide, was recently isolated from the skin secretions of winter flounder (Pleuronectes americanus). The present study identifies the cDNA and gene encoding pleurocidin. The pleurocidin gene comprises four exons. Its upstream region demonstrates consensus binding sequences for transcription factors found in host defense genes in mammals, including sequences identical to the NF-IL6 and alpha and gamma interferon response elements. Pleurocidin is predicted to exist as a 68-residue prepropeptide that undergoes proteolytic cleavage of its amino-terminal signal and carboxy-terminal anionic propiece to form the active, mature peptide. Transmission electron microscopy localized pleurocidin to the mucin granules of skin and intestinal goblet cells. Significant synergy was shown to occur between pleurocidin and D-cycloserine targeting Mycobacterium smegmatis. Pleurocidin was functionally active at physiologic concentrations of magnesium and calcium; however, high concentrations of these divalent cations ablated pleurocidin's activity against a standard test strain, Escherichia coli D31. Pleurocidin was tested against bacterial and fungal clinical isolates and showed broad-spectrum antimicrobial activity. Together, these data support the hypothesis that pleurocidin participates in innate mucosal immunity, and it may prove to be a beneficial therapeutic agent.


Assuntos
Antibacterianos/farmacologia , Linguado , Proteínas/genética , Proteínas/farmacologia , Pseudomonas aeruginosa/efeitos dos fármacos , Sequência de Aminoácidos , Animais , Antibacterianos/isolamento & purificação , Sequência de Bases , Cálcio/farmacologia , Clonagem Molecular , Ciclosserina/farmacologia , DNA Complementar/metabolismo , Sinergismo Farmacológico , Proteínas de Peixes , Células Caliciformes/metabolismo , Células Caliciformes/ultraestrutura , Humanos , Intestino Delgado/metabolismo , Intestino Delgado/ultraestrutura , Klebsiella pneumoniae/efeitos dos fármacos , Magnésio/farmacologia , Testes de Sensibilidade Microbiana , Dados de Sequência Molecular , Peptídeos/genética , Peptídeos/farmacologia , Proteínas/metabolismo , Pele/metabolismo , Pele/ultraestrutura , Staphylococcus aureus/efeitos dos fármacos , Frações Subcelulares
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA